EGFL7 and neoplasm: Grimolizzi et al., for example, reported miR-126-3p to induce cell proliferation and angiogenesis in non-tumorigenic cells, but also acting at the same time as a tumor suppressor and metastasis inhibitor by targeting IRS1, EGFL7, Crk, SLC7A513 [30,31].